Induced pluripotent stem cells meet genome editing

D Hockemeyer, R Jaenisch - Cell stem cell, 2016 - cell.com
It is extremely rare for a single experiment to be so impactful and timely that it shapes and
forecasts the experiments of the next decade. Here, we review how two such experiments …

Gene therapy for cystic fibrosis: new tools for precision medicine

JA Lee, A Cho, EN Huang, Y Xu, H Quach, J Hu… - Journal of translational …, 2021 - Springer
The discovery of the Cystic fibrosis (CF) gene in 1989 has paved the way for incredible
progress in treating the disease such that the mean survival age of individuals living with CF …

Classification of CFTR mutation classes.

FAL Marson, CS Bertuzzo, JD Ribeiro - The Lancet. Respiratory …, 2016 - europepmc.org
Classification of CFTR mutation classes. - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback …

[HTML][HTML] Gene therapy for cystic fibrosis: progress and challenges of genome editing

G Maule, D Arosio, A Cereseto - International journal of molecular …, 2020 - mdpi.com
Since the early days of its conceptualization and application, human gene transfer held the
promise of a permanent solution to genetic diseases including cystic fibrosis (CF). This field …

Efficient gene editing at major CFTR mutation loci

J Ruan, H Hirai, D Yang, L Ma, X Hou, H Jiang… - … therapy nucleic acids, 2019 - cell.com
Cystic fibrosis (CF) is a lethal autosomal recessive disease caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene. Nuclease-mediated precise …

Highly efficient gene editing of cystic fibrosis patient-derived airway basal cells results in functional CFTR correction

S Suzuki, AM Crane, V Anirudhan, C Barillà… - Molecular Therapy, 2020 - cell.com
There is a strong rationale to consider future cell therapeutic approaches for cystic fibrosis
(CF) in which autologous proximal airway basal stem cells, corrected for CFTR mutations …

[HTML][HTML] Personalized or precision medicine? The example of cystic fibrosis

FAL Marson, CS Bertuzzo, JD Ribeiro - Frontiers in pharmacology, 2017 - frontiersin.org
The advent of the knowledge on human genetics, by the identification of disease-associated
variants, culminated in the understanding of human variability. With the genetic knowledge …

[HTML][HTML] Cystic fibrosis: overview of the current development trends and innovative therapeutic strategies

FA Almughem, AM Aldossary, EA Tawfik, MN Alomary… - Pharmaceutics, 2020 - mdpi.com
Cystic Fibrosis (CF), an autosomal recessive genetic disease, is caused by a mutation in the
gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). This …

iPSC-derived intestinal organoids from cystic fibrosis patients acquire CFTR activity upon TALEN-mediated repair of the p. F508del mutation

A Fleischer, S Vallejo-Díez… - … Therapy Methods & …, 2020 - cell.com
Cystic fibrosis (CF) is the main genetic cause of death among the Caucasian population.
The disease is characterized by abnormal fluid and electrolyte mobility across secretory …

CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells

EJ Kim, KH Kang, JH Ju - The Korean Journal of Internal …, 2017 - pmc.ncbi.nlm.nih.gov
Recent advances in genome editing with programmable nucleases have opened up new
avenues for multiple applications, from basic research to clinical therapy. The ease of use of …